曲美他嗪治疗伴有糖尿病冠心病效果分析.docVIP

曲美他嗪治疗伴有糖尿病冠心病效果分析 　　【摘要】目的 探究曲美他嗪治??伴有糖尿病的冠心病的效果。方法 收集2012年3月～2015年3月我院收治的伴有糖尿病的冠心病患者70例进行研究，将上述患者随机分为对照组接受常规药物治疗，观察组在对照组治疗基础上加用曲美他嗪治疗，比较两组治疗效果、心功能指标、心绞痛情况以及血脂、血糖水平。 　　结果 ①观察组治疗有效率94.3%显著高于对照组77.1%，差异有统计学意义（P0.05）。②观察组心率左室射血分数（54.4±7.0）%、左室收缩末内径（40.2±4.5）mm、左室舒张末期内径（53.3±6.9）mm显著优于对照组（49.4±7.3）%、（44.6±4.3）mm、（56.3±6.2）mm，组间比较差异有统计学意义（P0.05）。观察组患者心绞痛发作频率、持续时间均显著低于对照组，组间比较差异有统计学意义（P0.05）。③观察组患者血脂水平、血糖水平均显著优于对照组，组间比较差异有统计学意义（P0.05）。结论 曲美他嗪治疗伴有糖尿病的冠心病效果显著，值得深入推广。 　　【关键词】曲美他嗪；糖尿病；冠心病 　　【中图分类号】R541 【文献标识码】B 【文章编号】ISSN.2095-6681.2016.20.0.02 　　The trimetazidine treatment effect of 70 patients Suffered 　　from CHD and diabetes 　　SI Xiao-yun，LIAO Fu-jun*，SHI Lin-yan，SUN Wei-hong，TANG Qian，WANG Long，HU Huan 　　（Department of Cardiology， the Affiliated Hospital of Guizhou Medical University， 　　Guizhou Guiyang 550004，China） 　　【Abstract】Objective QuMei trimetazidine treatment on coronary heart disease with diabetes effect.Methods From March 2012 to March 2015 in our hospital， patients with diabetes and 70 patients with coronary heart disease were studied. The patients were randomly divided into the control group received routine treatment， the observation group in the control group treated with Sibutramine trimetazidine treatment， treatment effects were compared between the two groups， the indexes of heart function， angina pectoris and blood lipid， blood glucose level.Results The observation group treatment effective rate of94.3% was significantly higher than77.1% in the control group， the difference was statistically significant（P0.05）.The observation group heart rate of left ventricular ejection fraction（54.4+7）%，left ventricular end systolic diameter（40.2+4.5）mm， left ventricular end diastolic diameter（53.3+6.9）was significantly higher than that of mm the control group（49.4+7.3）% and（44.6+4.3）mm，（56.3+6.2）mm， there were significant differences between the groups（P0.05）.The observation group of patients with angina attack frequency， duration were significantly lower